Sincalide Injection, Powder, Lyophilized, For Solution
Product Images NDC 70511-131

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sincalide (NDC 70511-131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Maia Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sincalide Structure (Sincalide Structure)

This is a peptide sequence consisting of eight amino acids (Aspartic acid, Tyrosine, Methionine, Glycine, Tryptophan, Methionine, Aspartic acid, Phenylalanine) with a molecular weight of 114327 g/mol. The CAS number for this compound is 25126-32-3.*

FDA Label Image

Vial Label (Vial)

Sincalide is a lyophilized powder containing 5 mcg of sincalide, intended for intravenous administration. The recommended dosage should be consulted in the prescribing information. The vial is for single use only and any unused portion should be discarded. It should be stored between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The product is manufactured by MAIA Pharmaceuticals, Inc. The Lot number and the expiration date are also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.